NeuroSearch – Financial calendar for 2013

1/8/2013 4:34 AM EST

NeuroSearch A/S
Financial Calendar

NeuroSearch – Financial calendar for 2013

Announcement
08.01.2013



NeuroSearch A/S (NEUR) hereby announces the company’s financial calendar for
2013: 


Financial calendar for 2013

8 February 2013   Annual Report 2012                               
20 March 2013     Annual General Meeting                           
25 April 2013     Interim report for the first three months of 2013
29 August 2013    Interim report for the first six months of 2013  
14 November 2013  Interim report for the first nine months of 2013 


René Schneider
CEO


Contact person
René Schneider, CEO, telephone: +45 2911 2097



About NeuroSearch
NeuroSearch A/S (NEUR) is listed on NASDAQ OMX Copenhagen A/S. The company’s
product pipeline comprises ordopidine and seridopidine, which have both
completed phase I studies, as well as tesofensine, which has completed phase
II, and NS2359 which has completed phase I.  All drug candidates exert their
effect in the central nervous system.